Drug intelligence / Profile preview

Hyoscine butylbromide + dipyrone

Development stage
Unknown
Lead developer
Boehringer Ingelheim
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Rectal
01

Overview

Hyoscine butylbromide + dipyrone is a fixed-dose combination of two active pharmaceutical ingredients used primarily for the symptomatic treatment of abdominal pain and cramping associated with gastrointestinal or urinary tract spasms. Hyoscine butylbromide (also known as scopolamine butylbromide) is an antispasmodic and anticholinergic agent that acts as a peripherally acting muscarinic acetylcholine receptor antagonist, leading to smooth muscle relaxation in the gastrointestinal and genitourinary tracts[3][4][5]. Dipyrone (also known as metamizole) is a non-opioid analgesic and antipyretic that provides pain relief by inhibiting prostaglandin synthesis via cyclooxygenase inhibition[1][2][7]. The combination offers both spasmolytic (muscle-relaxing) and analgesic effects. It is widely used in several countries for conditions such as colicky abdominal pain, including those due to irritable bowel syndrome or renal colic. The product is not approved in some regions due to safety concerns related to dipyrone.

Brand names
Buscopan CompositumBusconet
Other names
hyoscine-N-butylbromide + metamizolescopolamine butylbromide + dipyronescopolamine butylbromide + metamizole
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)CHRM3 (M3)Nicotinic Acetylcholine ReceptorCHRM5 (M5)CHRM2 (M2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Hyoscine butylbromide + dipyrone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyoscine butylbromide + dipyrone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call